Drug Trial Radar · NCT07787169
A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease
Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
179
Planned (sponsor's estimate)
Start
Sep 9, 2026
Primary completion
Jul 2028
Study completion Jul 2028
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Aug 26, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Screening
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this Master Protocol is to support multiple studies looking at safety and tolerability of different drugs in healthy participants and participants with Alzheimer's disease, and if they remove clumps of protein (amyloid plaque) in the brain in participants with Alzheimer's Disease. Participants will enroll into either A1D-MC-AT01 (NCT07787182) or A1D-MC-AT02 (upcoming).
Conditions
- Alzheimer Disease
- Amyloid
- Plaque, Amyloid
- Healthy Volunteers
Interventions
LY4405094Drug
Administered intravenously (IV)
LY4405094Drug
Administered Subcutaneously (SC)
PlaceboDrug
Administered IV
PlaceboDrug
Administered SC
Florbetapir F18Other
Administered IV
Florbetaben F 18Other
Administered IV
Primary outcomes
What the sponsor says the trial is designed to measure.
- The number of participants allocated to each substudyTime frame: Baseline up to Day 160
Locations
19 sites in 3 countries. Site status is shown where the registry gives one.
CenExel ACT
Anaheim, California · Recruiting
Irvine Clinical Research
Irvine, California · Not yet recruiting
Collaborative Neuroscience Network - CNS
Los Alamitos, California · Recruiting
Fortrea Clinical Research Unit
Daytona Beach, Florida · Recruiting
K2 Medical Research - The Villages
Lady Lake, Florida · Not yet recruiting
K2 Medical Research
Maitland, Florida · Not yet recruiting
Charter Research
Orlando, Florida · Not yet recruiting
Progressive Medical Research
Port Orange, Florida · Not yet recruiting
Alzheimer's Research and Treatment Center
Stuart, Florida · Not yet recruiting
K2 Medical Research - Tampa
Tampa, Florida · Not yet recruiting
Charter Research
The Villages, Florida · Not yet recruiting
Accel Research Sites - NeuroStudies Clinical Research Unit
Decatur, Georgia · Not yet recruiting
QUEST Research Institute
Farmington Hills, Michigan · Not yet recruiting
Xuanwu Hospital Capital Medical University
Beijing, China · Not yet recruiting
Peking University Third Hospital
Beijing, China · Not yet recruiting
Huashan Hospital, Fudan University
Minhang District, China · Not yet recruiting
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, China · Not yet recruiting
The University of Tokyo Hospital
Bunkyō City, Japan · Not yet recruiting
National Center for Geriatrics and Gerontology
Ōbu, Japan · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.